Test of a Homeopathic Dilution of Aconitum napellus A Clinical, Randomized, Double-Blind, Controlled Crossover Study in Healthy Volunteers

被引:6
作者
Piltan, Daryoush [1 ]
Rist, Lukas [1 ]
Simoes-Wuest, A. Paula [1 ]
Saller, Reinhard [2 ]
机构
[1] Paracelsus Hosp, Res Dept, CH-8805 Richterswil, Switzerland
[2] Univ Zurich Hosp, Inst Complementary Med, Dept Internal Med, Zurich, Switzerland
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2009年 / 16卷 / 03期
关键词
Homeopathic potencies; Aconitum napellus; Randomized trial; Crossover study; Placebo; Humans; PROSTATE-CANCER GROWTH; PLACEBO; TRIALS; METAANALYSIS; POTENCIES;
D O I
10.1159/000219316
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Although healthy persons often report on reactions to homeopathically diluted substances, the mechanism behind such reactions remains unclear. This study examines whether a distinction can be made between the short-term reactions of healthy volunteers to a homeopathically diluted substance-Aconitum napellus C30 - and to a placebo. Participants and Methods: From the 33 subjects randomized for this double-blind, placebo-controlled crossover study, 27 could be included in the analysis. The study comprised two 7-day-long treatment periods, each including the intake of a study preparation for 3 days and a wash-out period of 4 days. One group was first treated with Aconitum napellus C30 and then with placebo; the other group received the two study preparations in the reverse order. The signs and symptoms before the first treatment and after each treatment were collected, evaluated, weighted and repertorized. Based on this classification the blinded physician assessed these signs and symptoms as study outcome parameter to represent the responses to each of the study preparations. Statistical analysis of the data was performed using the Wilcoxon-Mann-Whitney rank test. Results: Crossover differences yielded statistical significance between the classified reactions towards Aconitum napellus C30 and to placebo (p = 0.004). Conclusions: A clear difference between the reported short-term reactions of healthy subjects towards Aconitum napellus C30 and towards placebo was shown. The crossover design with intra-individual comparisons proved to be adequate to recognize the study preparations and for the statistical analysis of a small population sample.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 50 条
  • [41] Acute Metabolic Responses to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled Trial
    Eckstein, Max L.
    Brockfeld, Antonia
    Haupt, Sandra
    Schierbauer, Janis R.
    Zimmer, Rebecca T.
    Wachsmuth, Nadine
    Zunner, Beate
    Zimmermann, Paul
    Obermayer-Pietsch, Barbara
    Moser, Othmar
    NUTRIENTS, 2021, 13 (11)
  • [42] Moral decision making under modafinil: a randomized placebo-controlled double-blind crossover fMRI study
    Ngo, Thao
    Ghio, Marta
    Kuchinke, Lars
    Roser, Patrik
    Bellebaum, Christian
    PSYCHOPHARMACOLOGY, 2019, 236 (09) : 2747 - 2759
  • [43] Acupuncture for Japanese Katakori (Chronic Neck Pain): A Randomized Placebo-Controlled Double-Blind Study
    Takakura, Nobuari
    Takayama, Miho
    Kawase, Akiko
    Kaptchuk, Ted J.
    Kong, Jian
    Vangel, Mark
    Yajima, Hiroyoshi
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [44] Moclobemide in social phobia - A double-blind, placebo-controlled clinical study
    Burrows, G
    Evans, L
    Baumhackl, U
    Hebenstreit, H
    Katschnig, H
    Schony, W
    Scholz, H
    Wilmotte, J
    Campos, J
    Costa, D
    Nardi, A
    Versiani, M
    daSilva, A
    Bowen, R
    Bradwejn, J
    Johnston, D
    Plamondon, J
    Stein, M
    Swinson, R
    Chneiweiss, L
    Bellaire, W
    Osterheider, M
    Sonntag, R
    Cookson, J
    Freeman, C
    Hirsch, S
    Mullin, J
    Murray, R
    Nutt, D
    Petursson, H
    ODonoghue, F
    Min, J
    Allgulander, C
    Andersch, S
    Backa, H
    Realini, R
    Siegel, JL
    Buller, R
    Katschnig, H
    Stein, MB
    Buller, R
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1997, 247 (02) : 71 - 80
  • [45] Moclobemide in social phobiaA double-blind, placebo-controlled clinical study
    H. Katschnig
    European Archives of Psychiatry and Clinical Neuroscience, 1997, 247 (2) : 71 - 80
  • [46] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
    Lisa M. Pitchford
    Patricia M. Driver
    John C. Fuller
    Wendell S. Akers
    Naji N. Abumrad
    Venkataraman Amarnath
    Ginger L. Milne
    Sheau-Chiann Chen
    Fei Ye
    L. Jackson Roberts
    M. Benjamin Shoemaker
    John A. Oates
    John A. Rathmacher
    Olivier Boutaud
    BMC Pharmacology and Toxicology, 21
  • [47] A double-blind placebo-controlled study into the efficacy of a homeopathic remedy for fear of firework noises in the dog (Canis familiaris)
    Cracknell, Nina R.
    Mills, Daniel S.
    VETERINARY JOURNAL, 2008, 177 (01) : 80 - 88
  • [48] A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression
    Tohen, M.
    McDonnell, D. P.
    Case, M.
    Kanba, S.
    Ha, K.
    Fang, Y.
    Katagiri, H.
    Gomez, J. C.
    BIPOLAR DISORDERS, 2011, 13 : 100 - 100
  • [49] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
    Pitchford, Lisa M.
    Driver, Patricia M.
    Fuller, John C., Jr.
    Akers, Wendell S.
    Abumrad, Naji N.
    Amarnath, Venkataraman
    Milne, Ginger L.
    Chen, Sheau-Chiann
    Ye, Fei
    Roberts, L. Jackson, II
    Shoemaker, M. Benjamin
    Oates, John A.
    Rathmacher, John A.
    Boutaud, Olivier
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [50] Spinal manipulation: A systematic review of sham-controlled, double-blind, randomized clinical trials
    Ernst, E
    Harkness, E
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (04) : 879 - 889